| Name | Walgreens #19958 |
|---|---|
| Organization Name | Walgreen Co |
| Location | 300 W Main St, Bridgeport, West Virginia 26330 |
| Type | Community/Retail Pharmacy |
| Phone | (304) 842-3131 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Associations between population density, neighbourhood deprivation and the risk of developing schizophrenia or depression can be attributed to familial selection factors rather than the local environment itself, research suggests.
Training becomes even more challenging when budgets and resources are stretched thin. URAC, the nation's leading health care accreditation and education organization, has expanded its online courses to help health care professionals receive the training they need. The flexible courses cover a wide range of health care topics and are available in a variety of formats, including webinars and eLearning modules.
Celldex Therapeutics, Inc. today announced key in vivo efficacy data for its CDX-1135 program from a collaboration with Drs. Richard Smith and Carla Nester at the University of Iowa.
Eliza Corporation, the pioneer and recognized leader in Health Engagement Management, today announced that it has received a notice of allowance from the United States Patent and Trademark Office (USPTO) for a Complex Acoustic Resonance Speech Analysis System.
PharmaMar announces that Janssen Research & Development, LLC has submitted a New Drug Application (NDA) for YONDELIS (trabectedin) to the U.S. Food and Drug Administration for the treatment of patients with advanced soft tissue sarcoma (STS), including liposarcoma and leiomyosarcoma subtypes, who have received prior chemotherapy including an anthracycline.
› Verified 4 days ago
| NPI Number | 1679110290 |
| Type | Community/Retail Pharmacy |
| Address | 300 W Main St, Bridgeport, WV 26330 |
| Phone Number | 304-842-3131 |
News Archive
Associations between population density, neighbourhood deprivation and the risk of developing schizophrenia or depression can be attributed to familial selection factors rather than the local environment itself, research suggests.
Training becomes even more challenging when budgets and resources are stretched thin. URAC, the nation's leading health care accreditation and education organization, has expanded its online courses to help health care professionals receive the training they need. The flexible courses cover a wide range of health care topics and are available in a variety of formats, including webinars and eLearning modules.
Celldex Therapeutics, Inc. today announced key in vivo efficacy data for its CDX-1135 program from a collaboration with Drs. Richard Smith and Carla Nester at the University of Iowa.
Eliza Corporation, the pioneer and recognized leader in Health Engagement Management, today announced that it has received a notice of allowance from the United States Patent and Trademark Office (USPTO) for a Complex Acoustic Resonance Speech Analysis System.
PharmaMar announces that Janssen Research & Development, LLC has submitted a New Drug Application (NDA) for YONDELIS (trabectedin) to the U.S. Food and Drug Administration for the treatment of patients with advanced soft tissue sarcoma (STS), including liposarcoma and leiomyosarcoma subtypes, who have received prior chemotherapy including an anthracycline.
› Verified 4 days ago
| NPI Number | 1730606492 |
| Organization Name | WALGREEN CO |
| Doing Business As | WALGREENS # 19958 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 300 W Main St, Bridgeport, WV 26330 |
| Phone Number | 304-842-3131 |
News Archive
Associations between population density, neighbourhood deprivation and the risk of developing schizophrenia or depression can be attributed to familial selection factors rather than the local environment itself, research suggests.
Training becomes even more challenging when budgets and resources are stretched thin. URAC, the nation's leading health care accreditation and education organization, has expanded its online courses to help health care professionals receive the training they need. The flexible courses cover a wide range of health care topics and are available in a variety of formats, including webinars and eLearning modules.
Celldex Therapeutics, Inc. today announced key in vivo efficacy data for its CDX-1135 program from a collaboration with Drs. Richard Smith and Carla Nester at the University of Iowa.
Eliza Corporation, the pioneer and recognized leader in Health Engagement Management, today announced that it has received a notice of allowance from the United States Patent and Trademark Office (USPTO) for a Complex Acoustic Resonance Speech Analysis System.
PharmaMar announces that Janssen Research & Development, LLC has submitted a New Drug Application (NDA) for YONDELIS (trabectedin) to the U.S. Food and Drug Administration for the treatment of patients with advanced soft tissue sarcoma (STS), including liposarcoma and leiomyosarcoma subtypes, who have received prior chemotherapy including an anthracycline.
› Verified 4 days ago
News Archive
Associations between population density, neighbourhood deprivation and the risk of developing schizophrenia or depression can be attributed to familial selection factors rather than the local environment itself, research suggests.
Training becomes even more challenging when budgets and resources are stretched thin. URAC, the nation's leading health care accreditation and education organization, has expanded its online courses to help health care professionals receive the training they need. The flexible courses cover a wide range of health care topics and are available in a variety of formats, including webinars and eLearning modules.
Celldex Therapeutics, Inc. today announced key in vivo efficacy data for its CDX-1135 program from a collaboration with Drs. Richard Smith and Carla Nester at the University of Iowa.
Eliza Corporation, the pioneer and recognized leader in Health Engagement Management, today announced that it has received a notice of allowance from the United States Patent and Trademark Office (USPTO) for a Complex Acoustic Resonance Speech Analysis System.
PharmaMar announces that Janssen Research & Development, LLC has submitted a New Drug Application (NDA) for YONDELIS (trabectedin) to the U.S. Food and Drug Administration for the treatment of patients with advanced soft tissue sarcoma (STS), including liposarcoma and leiomyosarcoma subtypes, who have received prior chemotherapy including an anthracycline.
› Verified 4 days ago
Apria Healthcare Llc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2891 Benedum Dr, Bridgeport, West Virginia 26330 Phone: (304) 842-9580 | |
Lincare Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2324 Murphys Run Rd, Bridgeport, West Virginia 26330 Phone: (304) 566-3038 | |
Cvs Pharmacy # 16949 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2800 Meadowbrook Mall, Bridgeport, West Virginia 26330 Phone: (304) 842-7779 | |
Walgreens #19958 Type: Community/Retail Pharmacy Location: 300 W Main St, Bridgeport, West Virginia 26330 Phone: (304) 842-3131 | |
Gateway Home Care Type: Durable Medical Equipment & Medical Supplies Supplier Location: 129 E Main St, Bridgeport, West Virginia 26330 Phone: (681) 342-3370 |